Related Experiment Video
Updated: Jun 11, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis
Kayoko Kaneko1, Toshihiro Nanki, Tadashi Hosoya
1Department of Medicine and Rheumatology, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
Abstract:
We present two patients with rheumatoid arthritis (RA) who developed necrotizing crescentic glomerulonephritis (NCGN) during etanercept therapy. Both patients developed proteinuria and hematuria, and one progressed to renal failure. Renal biopsy revealed NCGN. In both patients, nephritis improved following discontinuation of etanercept and administration of prednisolone. Physicians should be aware of etanercept-induced GN in patients with RA on anti-tumor necrosis factor therapy.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Rheumatic Heart Disease I: Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

